ME
Markus Enzelberger
Partner Versant Ventures
Greater Munich Metropolitan Area
Overview
Markus Enzelberger is a Partner at Versant Ventures, actively involved in investing in pharmaceutical and biotech companies at various stages. With a background in molecular biology and biochemistry, he has held board positions in several innovative biotech firms, including SixPeaks Bio and Matterhorn Biosciences.
Enzelberger's career highlights include serving as a Board Member for SixPeaks Bio and Matterhorn Biosciences, demonstrating his strategic leadership in the biotech industry and his ability to drive growth and innovation in these organizations.
Work Experience
Board Member
2023 - Current
Partner
2020
Entrepreneur in Residence
2020 - 2020
Launch of future newcos from Versant's Ridgeline Discovery Engine.
Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Board Member
2022
Board Member
2021
Board Observer
2021
Board Member
2020
Board Member
2020
Ridgeline Therapeutics is emerging biotechnology developing new drugs to cure Type 2 diabetes, muscular, age-related muscle degeneration.
Board Member
2020
Senior Advisor
2017
Board Observer
2020